PHARMAC has rejected funding for the drug Kadcyla, used to treat breast cancer
PHARMAC has rejected funding for the drug Kadcyla, used to treat breast cancer
23 April 2019
The health select committee considered a petition earlier this month calling for Pharmac to fully fund the drug.
The petition was signed by close to 34 thousand people.
Breast Cancer Aotearoa Chair Libby Burgess says the decision is in direct contradiction to PHARMAC's own clinical experts.
The drug has been funded in Australia since 2015.
© 2024 Newstalk ZB, NZCity